Rare diseases
Investigational molecules
Locations
Back to Germany4 clinical trials in Donaustauf, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Study of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis
GermanyA study of the humanised IgG1 lalaps-yte monoclonal antibody against lysophosphatidic acid receptor 1 to treat adults with idiopathic pulmonary fibrosis
GermanyA Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation
GermanyStudy on BI 1819479 to Improve Lung Function in Patients with Idiopathic Pulmonary Fibrosis
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on idiopathic pulmonary fibrosis (IPF), a progressive lung condition that affects respiratory function. These trials aim to evaluate new therapeutic approaches for improving lung function in affected patients.
Research efforts include comparative studies between various treatment doses and placebo to determine optimal therapeutic effectiveness for patients with pulmonary conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
